Back to search

Article

MCT4 Upregulates PD-L1 Expression and Defines Novel Composite Therapeutic Targets for Triple-Negative Breast Cancer

2021-07-30

Abstract excerpt

<title>Abstract</title> <p>Immune checkpoint blocking therapy targeting the PD-1/PD-L1 axis has shown promising availability for triple-negative breast cancer (TNBC). Nevertheless, in some cases, targeting efficiency is low and efficient gene interaction networks need to be sought, which inspired the exploration that MCT4 and PD-L1 co-expression network analysis and potential regulatory mechanism research. In the...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
114d35f5-400f-5d3d-8b25-4f32d879363a
DOI
10.21203/rs.3.rs-736015/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
MCT4 Upregulates PD-L1 Expression and Defines Novel Composite Therapeutic Targets for Triple-Negative Breast CancerDOI 10.21203/rs.3.rs-736015/v1
Select a neighboring publication to make it the new centre.